Vissza |
Bacsur Péter; Matuz Mária; Resál Tamás; Miheller Pál; Szamosi Tamás; Schäfer Eszter; Sarlós Patrícia; Iliás Ákos; Szántó Kata Judit; Rutka Mariann; Bálint Anita; Milassin Ágnes; Fábián Anna; Bor Renáta; Szepes Zoltán; Molnár Tamás; Farkas Klaudia:
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 15 (January-December).
pp. 1-18.
ISSN 1756-283X
(2022)